for borderline resectable GIST . J Natl Compr Canc Netw 2012 ; 10 : 1477 – 1482 ; quiz 1482 . 6. Corless CL Ballman KV Antonescu CR . Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected
Search Results
Pathologic Complete Response in a Large Gastric GIST: Using Molecular Markers to Achieve Maximal Response to Neoadjuvant Imatinib
Joshua B. Brown, Reetesh K. Pai, Melissa A. Burgess, Jennifer Chennat, and Amer H. Zureikat
Multigene Testing in Localized Prostate Cancer
Ashley E. Ross
. 10. Klein EA Yousefi K Haddad Z . A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy . Eur
Novel Approaches to Advanced Breast Cancer: Bevacizumab and Lapatinib
Erica L. Mayer, Nancy U. Lin, and Harold J. Burstein
Yothers G Romond E . Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2
Chemotherapy in the Management of Osteosarcoma and Ewing's Sarcoma
Scott M. Schuetze
. Adjuvant therapy of osteosarcoma—a phase II trial: Southwest Oncology Group study 9139 . Cancer 2004 ; 100 : 818 – 825 . 33. Voute PA Souhami RL Nooij M . A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial
The Role of Radiation Treatment in the Contemporary Management of Bone Tumors
Borislav Hristov, Ori Shokek, and Deborah A. Frassica
curettage without adjuvant therapy provide low recurrence rates in giant-cell tumors of bone? Clin Orth Rel Res 2005 ; 435 : 211 – 218 . 49. Chen ZX Gu DZ Yu ZH . Radiation therapy of giant cell tumor of bone: analysis of 35 patients . Int J
Immune-Related Adverse Events Among COVID-19–Vaccinated Patients With Cancer Receiving Immune Checkpoint Blockade
Adam J. Widman, Bevin Cohen, Vivian Park, Tara McClure, Jedd Wolchok, and Mini Kamboj
For example, a recent study of pembrolizumab as adjuvant therapy in 509 patients with resected stage III melanoma found an irAE incidence of 19% within 3 months of treatment initiation 6 ; most irAEs were mild. No differences were observed in the risk
Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal
Masumi Ueda, Renato Martins, Paul C. Hendrie, Terry McDonnell, Jennie R. Crews, Tracy L. Wong, Brittany McCreery, Barbara Jagels, Aaron Crane, David R. Byrd, Steven A. Pergam, Nancy E. Davidson, Catherine Liu, and F. Marc Stewart
patients, adjuvant therapy with curative intent likely should proceed, despite the threat of COVID-19 infection during treatment. For patients with metastatic disease, treatment delays may lead to worsening performance status and loss of the window to treat
The Role of Inhibitors of the Epidermal Growth Factor in Management of Head and Neck Cancer
Bruce Brockstein, Mario Lacouture, and Mark Agulnik
Edited by Kerrin G. Robinson
(CRT) followed by G adjuvant therapy for locally advanced head and neck cancer (HNC) [abstract] . J Clin Oncol 2007 ; 25 ( Suppl 1 ): Abstract 6028 . 59. Herchenhorn D Dias FL Pineda RM . Phase II study of erlotinib combined with
Ovarian Cancer Biomarkers: Current Options and Future Promise
Christine M. Coticchia, Jiang Yang, and Marsha A. Moses
Group experience . J Clin Oncol 1991 ; 9 : 1138 – 1150 . 6. Young RC Walton LA Ellenberg SS . Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials . N Engl J Med 1990 ; 322
Modification and Implementation of NCCN Guidelines™ on Hepatobiliary Cancers in the Middle East and North Africa Region
Muhammed Aasim Yusuf, Vinay Kumar Kapoor, Refaat Refaat Kamel, Ather Kazmi, Najam Uddin, Nehal Masood, and Abdulmajeed Al-Abdulkareem
hepatocellular carcinoma . Liver Transpl 2005 ; 11 : 1086 – 1092 . 14. Llovet JM Mas X Aponte JJ . Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation . Gut 2002 ; 50 : 123 – 128
